PTX Capital

PTX Capital is a venture capital firm based in New York, New York, focusing on early-stage investments in the healthcare, life sciences, and biotechnology sectors. The firm seeks to support innovative companies addressing critical challenges in these industries.

Established in 2021, PTX Capital has been actively investing in the United States, with a particular emphasis on healthcare and biotechnology sectors. The firm's investment strategy includes participating in seed and Series A funding rounds, with investment sizes ranging from $20 million to $225 million.

PTX Capital's portfolio includes companies such as Delfi Diagnostics, which raised $225 million in a Series B round on July 18, 2022, and ArrePath, which secured $20 million in a seed round on March 3, 2022. The firm continues to seek opportunities to invest in early-stage companies within its focus areas.